Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses.
about
Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current DevelopmentsCD8(+) T-cell immunity against cancer-testis antigens develops following allogeneic stem cell transplantation and reveals a potential mechanism for the graft-versus-leukemia effect.Identification of 4 novel HLA-B*40:01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivityCan a female donor for a male recipient decrease the relapse rate for patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation?Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantationFunctional expression cloning identifies COX-2 as a suppressor of antigen-specific cancer immunityLoci controlling lymphocyte production of interferon c after alloantigen stimulation in vitro and their co-localization with genes controlling lymphocyte infiltration of tumors and tumor susceptibility.Durable remission of renal cell carcinoma in conjuncture with graft versus host disease following allogeneic stem cell transplantation and donor lymphocyte infusion: rule or exception?Minor antigen distribution predicts site-specific graft-versus-tumor activity of adoptively transferred, minor antigen-specific CD8 T Cells.PD-1 blockade induces remissions in relapsed classical Hodgkin lymphoma following allogeneic hematopoietic stem cell transplantation.Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response.Single step multiple genotyping by MALDI-TOF mass spectrometry, for evaluation of minor histocompatibility antigens in patients submitted to allogeneic stem cell transplantation from HLA-matched related and unrelated donorImpact of sex incompatibility on the outcome of single-unit cord blood transplantation for adult patients with hematological malignancies.Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia.
P2860
Q28067102-893FAB31-826F-4A08-B5E0-A7BA76CE7F08Q34095668-73AE7EFD-A692-40A0-8BA3-B8726B33345EQ34196623-9E9E0676-2D5D-441C-A767-C45054786DA5Q35177432-63D052E8-B8D8-4774-9E2B-71544D6BD467Q35588845-2F565E3A-6DEF-4CEA-AE01-4A9926573095Q36292012-FB040A91-38F0-4145-BBBE-4C8A44AF2A77Q37420175-D0BAE167-21AA-41F0-8BC6-E39AE9D1C2E4Q37484001-2FC4C2B2-DBD8-4346-BC40-7D295984F261Q37719395-61495A8C-8F31-4C67-B721-E6FE240FD482Q41897195-89D5B38C-ACC7-470E-A820-7C0E3BC88605Q42084183-3479CAFC-8711-4C52-8DB0-4E60C41E4415Q42699915-A8E98A22-0A3B-4F61-97BB-E66CADF6D55FQ46958217-1F3E3DD5-0CAD-472F-AF8D-BCB8EFF62295Q49370276-B91BBD4D-499D-46EB-9700-FA5B10B6384E
P2860
Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Targeting minor histocompatibi ...... aft versus leukemia responses.
@en
type
label
Targeting minor histocompatibi ...... aft versus leukemia responses.
@en
prefLabel
Targeting minor histocompatibi ...... aft versus leukemia responses.
@en
P2093
P2860
P356
P1433
P1476
Targeting minor histocompatibi ...... aft versus leukemia responses.
@en
P2093
Anthony G Brickner
Hashem M Younes
Kwok Min Hui
P2860
P304
P356
10.1016/J.IT.2008.09.004
P577
2008-10-25T00:00:00Z